LIPO6X
Natural health product licensed in Canada
- Licence holder
- iNutrition Inc.
- NPN or DIN-HM
- 80044894
- Status
- Inactive licence
- Licence date
- 23 September 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Prégna-4,17-diène-3,16-dione Source : Guggulsterone | 10 milligramme | Not calculated |
| 3,7-dihydro-1,3,7-triméthyl-1H-purine-2,6-dione Source : Caféine | 100 milligramme | Not calculated |
Non-medicinal ingredients
Bleu FD&C n° 2, Glycérine, Eau purifiée, Acacia, Cellulose, Poly(sorbate) 80
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 2 days ; maximum: 3 days |
Uses authorised in Canada
Helps (temporarily) to relieve fatigue, promote endurance and enhance motor performance. Helps (temporarily) to promote alertness and wakefulness and to enhance cognitive performance. Helps to temporarily increase thermogenesis. Helps to temporarily increase basal metabolic rate.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Immediately discontinue if you experience gastrointestinal discomfort, any irregular bleeding, rapid heart beat, dizziness, severe headaches or shortness of breath. Hypersensitivity / allergy is known to occur, in which case, discontinue use.
- Contre-indications
Do not consume if you are taking decongestant-containing cold preparations (i.e. phenylephrine or pseudoephedrine), products containing ephedra or ephedrine, or other natural health products (e.g. bitter orange extract, octopamine) or medications which increase blood pressure. Consumption with other caffeine-containing products (e.g. medications, colas, cocoa, guarana, mate) is not recommended. Do not use if you are taking blood pressure medications (either antihypertensives or hypertensives), thyroid medications, sympathomimetics, or monoamine oxidase inhibitors (MAOIs).
- Précautions et mises en garde
DO NOT EXCEED 3 CAPSULES PER DAY. Do not take within 6 hours of sleep. Not for use by persons under the age of 18. Do not use if pregnant or nursing. Consult your physician prior to use if you have a medical condition including but not limited to: heart, liver, kidney or thyroid disease, psychiatric disorders, difficulty urinating, detrusor instability (overactive bladder syndrome),diabetes, high blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma, or if you are taking lithium. Discontinue 2 weeks prior to surgery. KEEP OUT OF REACH OF CHILDREN. This product is not intended as a substitute for sleep. Consult a healthcare practitioner if are you are taking beta-blockers (e.g. propanolol) or the calcium channel blockers (e.g. Diltiazem). Consult a healthcare practitioner if you have coagulation disorders and/or are at risk for bleeding or are taking anticoagulant or antiplatelet medication. Consult a health care practitioner prior to use if you are taking any medications for irregular rhythms, high cholesterol, congestive heart failure, blood thinners and diuretics as this product may interact with medications for these conditions.
Source
Official Health Canada record, licence 80044894
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.